9.94
+0.32
+(3.37%)
As of 8:16:34 AM GMT+1. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
566,341.00
551,807.00
497,020.00
590,824.00
Total Liabilities Net Minority Interest
73,767.00
62,121.00
42,296.00
87,305.00
Total Equity Gross Minority Interest
492,574.00
489,686.00
454,724.00
503,519.00
Total Capitalization
492,574.00
489,686.00
454,724.00
538,585.00
Common Stock Equity
492,574.00
489,686.00
454,724.00
503,519.00
Capital Lease Obligations
25,042.00
22,866.00
22,601.00
21,756.00
Net Tangible Assets
428,270.00
424,808.00
423,909.00
472,704.00
Working Capital
329,717.00
324,891.00
369,892.00
454,728.00
Invested Capital
492,574.00
489,686.00
454,724.00
543,460.00
Tangible Book Value
428,270.00
424,808.00
423,909.00
472,704.00
Total Debt
25,042.00
22,866.00
22,601.00
61,697.00
Share Issued
90,282.27
79,123.31
64,505.89
60,996.37
Ordinary Shares Number
90,282.27
79,120.74
64,505.89
60,996.37
Treasury Shares Number
--
2.57
--
--
12/31/2020 - 3/19/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0K4.BE Akero Therapeutics Inc
53.38
-0.67%
0K4.F Akero Therapeutics, Inc.
52.98
+2.63%
COYA Coya Therapeutics, Inc.
5.86
+0.17%
22UA.DE BioNTech SE
118.60
-0.42%
ANIX Anixa Biosciences, Inc.
2.9400
-2.00%
EDSA Edesa Biotech, Inc.
1.8900
+1.07%
VTYX Ventyx Biosciences, Inc.
2.0500
+5.67%
VKTX Viking Therapeutics, Inc.
33.69
+0.78%
AKRO Akero Therapeutics, Inc.
55.36
+2.52%